Correlation Between Akari Therapeutics and Achilles Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Akari Therapeutics and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Achilles Therapeutics.
Diversification Opportunities for Akari Therapeutics and Achilles Therapeutics
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akari and Achilles is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Achilles Therapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Achilles Therapeutics
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Achilles Therapeutics. In addition to that, Akari Therapeutics is 6.39 times more volatile than Achilles Therapeutics PLC. It trades about -0.25 of its total potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.22 per unit of volatility. If you would invest 99.00 in Achilles Therapeutics PLC on August 29, 2024 and sell it today you would earn a total of 8.00 from holding Achilles Therapeutics PLC or generate 8.08% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Akari Therapeutics PLC vs. Achilles Therapeutics PLC
Performance |
Timeline |
Akari Therapeutics PLC |
Achilles Therapeutics PLC |
Akari Therapeutics and Achilles Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Akari Therapeutics and Achilles Therapeutics
The main advantage of trading using opposite Akari Therapeutics and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Achilles Therapeutics vs. Assembly Biosciences | Achilles Therapeutics vs. Spero Therapeutics | Achilles Therapeutics vs. Instil Bio | Achilles Therapeutics vs. Nuvation Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |